Skip to main content

On the Possible Significance of TCDD Receptor Based Assays in Attempts to Estimate Environmental Health Hazards

  • Chapter
Individual Susceptibility to Genotoxic Agents in the Human Population

Abstract

Several attempts have been made and are being made to correlate individual responsiveness to certain health hazards with individual differences in inducibility of aryl hydrocarbon hydroxylase (AHH) activity [1–5]. Our approach to this problem is to attempt to measure the concentration of the cytosolic receptor (the 2,3,7,8-tetrachlorodibenzo-p-dioxin or TCDD receptor) believed to be involved in induction of AHH [6], rather than to study the enzyme induction [7–13]. From the field of steroid hormonal receptors we know that we can predict the responsiveness of individual cancer patients to hormonal therapy by monitoring their tumor content of steroid receptors [14–18]. It does not seem unreasonable to suggest that, by analogy, we might be able to predict an individual’s responsiveness to certain toxic agents by assaying that individual’s levels of receptor for the particular toxic chemical under study.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. E. Ward, B. Paigen, K. Steenland, R. Vincent, J. Minowada, H. L. Gurtoo, P. Sartoti, and M. B. Havens, Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer, Int. J. Cancer, 22: 384–389 (1978).

    Article  Google Scholar 

  2. T. L. McLemore, R. R. Martin, N. P. Wray, E. T. Cantrell, and D. L. Busbee, Dissociation between aryl hydrocarbon hydroxylase activity in cultured pulmonary macrophages and blood lymphocytes from lung cancer patients, Cancer Res., 38: 3805–3811 (1978).

    Google Scholar 

  3. R. E. Kouri, J. Oberdorf, D. J. Slomiany, and C. E. McKinney, A method for detecting aryl hydrocarbon hydroxylase activities in cryopreserved human lymphocytes, Cancer Letters, 14: 29–40 (1981).

    Article  Google Scholar 

  4. B. Paigen, E. Ward, A. Reilly, L. Houten, H. L. Gurtoo, J. Minowada, K. Steenland, M. B. Havens, and P. Sartori, Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes, Cancer Res., 41: 2757–2761 (1981).

    Google Scholar 

  5. T. L. McLemore, R. R. Martin, N. P. Wray, E. T. Cantrell, and D. L. Busbee, Reassessment of the relationship between aryl hydrocarbon hydroxylase and lung cancer, Cancer, 48: 1438–1443 (1981).

    Article  Google Scholar 

  6. A. Poland, E. Glover, and A. Kende, Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase, J. Biol. Chem., 251: 4936–4946 (1976).

    Google Scholar 

  7. J. Carlstedt-Duke, G. Elfström, M. Snochowski, B. Högberg, and J.- Å. Gustafsson, Detection of the 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) receptor in rat liver by isoelectric focusing in polyacrylamide gels, Toxicol. Lett., 2: 365–373 (1978).

    Article  Google Scholar 

  8. J. M. B. Carlstedt-Duke, G. Elfström, B. Högberg, and J.-Å. Gustafsson, Ontogeny of the rat hepatic receptor for 2,3,7,8- tetrachlorodibenzo-p-dioxin and its endocrine indpendence, Cancer Res., 39: 4653–4656 (1979).

    Google Scholar 

  9. J. M. B. Carlstedt-Duke, Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat, Cancer Res., 39: 3172–3176 (1979).

    Google Scholar 

  10. J. Carlstedt-Duke, M. Gillner, L.-A. Hansson, R. Toftgård, S. Gustafsson, B. Högberg, and J.-Å. Gustafsson, The molecular basis for the induction of aryl hydrocarbon hydroxylase: characteristics of the receptor protein for 2,3,7,8-tetrachlorodi- benzo-p-dioxin (TCDD), in: Biochemistry, Biophysics, and Regulation of Cytochrome P–450 (J.-Å. Gustafsson et al., eds.), pp. 147, Elsevier/North-Holland Biomedical Press (1980).

    Google Scholar 

  11. J. M. B. Carlstedt-Duke, U.-B. Harnemo, B. Högberg, and J.-Å. Gustafsson, Interaction of the hepatic receptor protein for 2,3,7,8-tetrachlorodibenzo-p-dioxin with DNA, Biochim. Biophys. Acta, 672: 131–141 (1981).

    Google Scholar 

  12. L. Poellinger, R. N. Kurl. J. Lund, M. Gillner, J. Carlstedt-Duke, B. H5gberg, and J.-Å. Gustafsson, High-affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in cell nuclei from rat liver, Biochim. Biophys. Acta, 714: 516–523 (1982).

    Google Scholar 

  13. J. Lund, R. N. Kurl, L. Poellinger, and J.- Å. Gustafsson, Cytosolic and nuclear binding proteins for 2,3,7,8-tetrachloro- dibenzo-p-dioxin in the rat thymus, Biochim. Biophys. Acta, 716: 16–23 (1982).

    Google Scholar 

  14. E. V. Jensen, B. E. Block, S. Smith, K. Kyser, and E. R. DeSombre, Estrogen receptors and breast cancer response to adrenalectomy, NCI Monograph-Prediction of responses in cancer therapy, 34: 55–61 (1971).

    Google Scholar 

  15. W. L. McGuire and G. C. Chamness, Studies on the estrogen receptor in breast cancer, in: Advances in Experimental Medicine and Biology (B. W. O’Malley and A. R. Means, eds.), Plenum Press, New York, 36:113136 (1973).

    Google Scholar 

  16. Ö. Wrange, B. Nordenskjöld, C. Silfverswärd, P. O. Granberg, and J.-Å. Gustafsson, Isoelectric focusing of estradiol receptor protein from human mammary carcinoma — a comparison to sucrose gradient analysis, Europ. J. Cancer. 12: 695–700 (1976).

    Article  Google Scholar 

  17. Ö. Wrange, B. Nordenskjöld, and J.-Å. Gustafsson, Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel, Analytical Biochemistry, 85: 461–475 (1978).

    Article  Google Scholar 

  18. J.- Å. Gustafsson, Å. Pousette, and Ö. Wrange, Predictive tests in treatment of breast and prostatic carcinoma based on steroid receptor assays, Trends in Pharmacological Sciences, 1980, 279–281.

    Google Scholar 

  19. Ö. Wrange, J. Carlstedt-Duke, and J.-Å. Gustafsson, Purification of the glucocorticoid receptor from rat liver cytosol, J. Biol. Chem., 254: 9284–9290 (1979).

    Google Scholar 

  20. G. M. Ringold, Glucocorticoid regulation of mouse mammary tumor virus gene expression, Biochim. Biophys. Acta, 560: 487–508 (1979).

    Google Scholar 

  21. J. Carlstedt-Duke, J.- Å. Gustafsson, and Ö. Wrange, Formation and characteristics of hepatic dexamethasone-receptor complexes of different molecular weight, Biochim. Biophys. Acta, 497: 507–524 (1977).

    Google Scholar 

  22. Ö. Wrange and J.- Å. Gustafsson, Separation of the hormone- and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis, J. Biol. Chem., 253: 856–865 (1978).

    Google Scholar 

  23. J. Carlstedt-Duke, Ö. Wrange, E. Dahlberg, J.- Å. Gustafsson, and B. HSgberg, Transformation of the glucocorticoid receptor in rat liver cytosol by lysosomal enzymes, J. Biol. Chem., 254: 1537–1539 (1979).

    Google Scholar 

  24. S. Okret, J. Carlstedt-Duke, Ö. Wrange, K. CarlstrSm, and J.- Å. Gustafsson, Characterization of an antiserum against the gluco-corticoid receptor, Biochim. Biophys. Acta, 677: 205–219 (1981).

    Google Scholar 

  25. J. Carlstedt-Duke, S. Okret, Ö. Wrange, and J.- Å. Gustafsson, Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains, Proc. Natl. Acad. Sci. USA, 79: 4260–4264 (1982).

    Article  ADS  Google Scholar 

  26. S. Okret, Y.-W. Stevens, J. Carlstedt-Duke, Ö. Wrange, J.- Å. Gustafsson, and J. Stevens, Absence of a glucocorticoid receptor domain responsible for biological effects in glucocorticoid-resistant mouse lymphoma P1798, Cancer Res., 43: 3127–3131 (1983)

    Google Scholar 

  27. F. Payvar, Ö. Wrange, J. Carlstedt-Duke, S. Okret, J.- Å. Gustafsson, and K. R. Yamamoto, Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo, Proc. Natl. Acad. Sci. USA, 78: 6628–6632 (1981).

    Article  ADS  Google Scholar 

  28. J.- Å. Gustafsson, S. A. Gustafsson, B. Nordenskjöld, S. Okret, C. SilfvarswMrd, and Ö. Wrange, Estradiol receptor analysis in human breast cancer tissue by isoelectric focusing in poly- acrylamideBgel, Cancer Res., 38: 4225–4228 (1978).

    Google Scholar 

  29. S. Okret, Ö. Wrange, B. Nordenskjöld, C. Silfverswärd, and J.- Å. Gustafsson, Estrogen receptor assay in human mammary carcinoma with the synthetic estrogen llß-methoxy-17α-ethinyl- l,3,5(10)-estratriene-3,17ß-diol (R 2858), Cancer Res., 38:3904–3909 (1978).

    Google Scholar 

  30. N.-0. Theve, K. Carlstrom, J.- Å. Gustafsson, S. Gustafsson, B. Nordenskjöld, H. Sköldefors, and Ö. Wrange, Oestrogen receptors and peripheral serum levels of oestradiol-173 in patients with mammary carcinoma, Europ. J. Cancer, 14(1337–1340 (1978).

    Article  Google Scholar 

  31. H. Westerberg, B. Nordenskjöld, Ö. Wrange, J.- Å. Gustafsson, S. Humla, N. O. Theve, C. Silfverswärd, and P.-O. Granberg, Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contents, Europ. J. Cancer, 14: 619–622 (1978).

    Article  Google Scholar 

  32. C. Silfverswärd, J.- Å. Gustafsson, S. A. Gustafsson, B. Nordenskjöld, A. Wallgren, and Ö. Wrange, Estrogen receptor analysis on fine needle aspirates and on histologic biopsies from human breast cancer, Europ. J. Cancer, 16: 1351–1357 (1980).

    Article  Google Scholar 

  33. C. Silfverswärd, J.- Å. Gustafsson, S. A. Gustafsson, S. Humla, B. Nordenskjöld, A. Wallgren, and Ö. Wrange, Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer, Cancer, 45: 2001–2005 (1980).

    Article  Google Scholar 

  34. Ö. Wrange, S. Humla, I. Ramberg, S. A. Gustafsson, L. Skoog, B. Nordenskjöld, and J. -L Gustafsson, Progestin-receptor analysis in human breast cancer cytosol by isoelectric focusing in slabs of polyacrylamide gel, J. Steroid Biochem., 14: 141–148 (1981).

    Article  Google Scholar 

  35. G. L. Greene, F. W. Fitch, and E. V. Jensen, Monoclonal antibodies to estrophilin: Probes for the study of estrogen receptors, Proc. Natl. Acad. Sci. USA, 77: 157–161 (1980).

    Article  ADS  Google Scholar 

  36. G. L. Greene, C. Nolan, J. P. Engler, and E. V. Jensen, Monoclonal antibodies to human estrogen receptor, Proc. Natl. Acad. Sci. USA, 77: 5115–5119 (1980).

    Article  ADS  Google Scholar 

  37. J.- Å. Gustafsson, P. Ekman, M. Snochowski, A. Zetterberg, A. Pousette, and B. Högberg, Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer, Cancer Res., 38: 4345–4348 (1978).

    Google Scholar 

  38. J.- Å. Gustafsson, P. Ekman, Å. Pousette, M. Snochowski, and B. Högberg, Demonstration of a progestin receptor in human benign prostatic hyperplasia and prostatic carcinoma, Investigative Urology, 15: 361–366 (1978).

    Google Scholar 

  39. P. Ekman, M. Snochowski, E. Dahlberg, and J.- Å. Gustafsson, Steroid receptors in metastatic carcinoma of the human prostate, Europ. J. Cancer, 15: 257–262 (1979).

    Article  Google Scholar 

  40. P. Ekman, M. Snochowski, A. Zetterberg, B. Högberg, and J.- Å. Gustafsson, Steroid receptor content in human prostatic carcinoma and response to endocrine therapy, Ancer, 44: 1173–1181 (1979).

    Google Scholar 

  41. B. R. Rao and W. G. Wiest, Receptors for progesterone, Gynecol. Oncol., 2: 239–248 (1974).

    Article  Google Scholar 

  42. K. Pollow, M. Schmidt-Gollwitzer, and J. Nevinny-Stickel, Progesterone receptors in normal human endometrium and endometrial carcinoma, in: Progesterone receptors in normal and neoplastic tissues ( W. L. McGuire, J. P. Raynaud, and E. E. Baulieu, eds.), Raven Press, New York, 1977, 313–338.

    Google Scholar 

  43. M. E. Lippman, R. H. Halterman, B. G. Leventhal, S. Perry, and E. B. Thompson, Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells, J. Clin. Invest., 52: 1715–1725 (1973).

    Article  Google Scholar 

  44. J. Stevens, Y. W. Stevens, and R. L. Rosenthal, Characterization of cytosolic and nuclear glucocorticoid-binding components in human leukemic lymphocytes, Cancer Res., 39: 4939–4948 (1979).

    Google Scholar 

  45. L.-A. Hansson, S. A. Gustafsson, J. Carlstedt-Duke, G. Gahrton, B. Högberg, and J.- Å. Gustafsson, Quantitation of the cytsolic glucocorticoid receptor in human normal and neoplastic leukocytes using isoelectric focusing in polyacrylamide gel, J. Steroid Biochem., 14: 757–764 (1981).

    Article  Google Scholar 

  46. H. Bojar, K. Maar, and W. Staib, The endocrine background of human renal cell carcinoma, I. Binding of the hihgly potent progestin R 5020 by tumor cytosol., Urol. Int., 34: 302–311 (1979).

    Article  Google Scholar 

  47. G. Concolino, F. DiSilverio, A. Marocchi, and U. Bracci, Renal cancer steroid receptors: Biochemical basis for endocrine therapy, Eur. Urol., 5: 90–93 (1979).

    Google Scholar 

  48. A. Poland and E. Glover, Comparison of 2,3,7,8-tetrachlorodi-benzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene, Mol. Pharmacol., 10: 349–359 (1974).

    Google Scholar 

  49. A. Poland and E. Glover, Chlorinated dibenzo-p-dioxins: potent inducers of δ-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase II. A study of the structure-activity relationship, Mol. Pharmacol., 9: 736–747 (1973).

    Google Scholar 

  50. A. P. Poland, E. Glover, J. R. Robinson, and D. W. Nebert, Genetic expression of aryl hydrocarbon hydroxylase activity, J. Biol. Chem., 249: 5599–5606 (1974).

    Google Scholar 

  51. G. W. Lucier, O. S. McDaniel, and G. E. R. Hook, Nature of the enhancement of hepatic uridine diphosphate glucuronyltransferase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Biochem. Pharmacol., 24: 325–334 (1975).

    Article  Google Scholar 

  52. R. Kirsch, G. Fleischner, K. Kaminaka, and I. M. Arias, Structural and functional studies of ligandin, a major renal organic anion-binding protein, J. Clin. Invest., 55: 1009–1019 (1975).

    Article  Google Scholar 

  53. D. W. Nebert and H. V. Gelboin, Substrate-inducible microsomal aryl hydrocarbon hydroxylase in mammalian cell culture, II. Cellular responses during enzyme induction, J. Biol. Chem., 243: 6250–6261 (1968).

    Google Scholar 

  54. D. W. Nebert and H. V. Gelboin, The role of ribonucleic acid and protein synthesis in microsomal aryl hydrocarbon hydroxylase induction in cell culture. The independence of transcription and translation, J. Biol. Chem., 245: 160–168 (1970).

    Google Scholar 

  55. K. T. Kitchin and J. S. Woods, 2,3,7,8-tetrachlorodibenzo-p-dioxin induction of aryl hydrocarbon hydroxylase in female rat liver, Evidence for de novo synthesis of cytochrome P-448, Mol. Pharmacol., 14: 890–899 (1978).

    Google Scholar 

  56. D. A. Haugen, M. J. Coon, and D. W. Nebert, Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with 3-naphtoflavone or phenobarbitol, J. Biol. Chem., 251: 1817–1827 (1976).

    Google Scholar 

  57. P. E. Thomas, R. E. Kouri, and J. J. Hutton, The genetics of aryl hydrocarbon hydroxylase induction in mice: a single gene difference between C57BL/7J and DBA/2J, Biochem. Genet., 6: 157–168 (1972).

    Article  Google Scholar 

  58. D. W. Nebert and J. E. Gielen, Genetic regulation of aryl hydrocarbon hydroxylase induction in mice, Fed. Proc., 31: 1315–1325 (1972).

    Google Scholar 

  59. D. W. Nebert, F. M. Goujon, and J. E. Gielen, Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse, Nat. New Biol., 236: 107–110 (1972).

    Google Scholar 

  60. D. W. Nebert, S. S. Thorgeirsson, and G. H. Lamberg, Genetic aspects of toxicity during development, Environ. Health Perspect., 18: 35–45 (1976).

    Article  Google Scholar 

  61. A. Poland and E. Glover, Genetic expression of aryl hydrocarbon hydroxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for a receptor mutation in genetically non-responsive mice, Mol. Pharmacol., 11: 389–398 (1975).

    Google Scholar 

  62. D. W. Nebert and H. V. Gelboin, The in vivo and in vitro induction of aryl hydrodarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states, Arch. Biochem. Biophys., 134: 76–89 (1969).

    Article  Google Scholar 

  63. B. A. Fowler, G. E. Hook, and G. W. Lucier, Tetrachlordibenzo-p-dioxin induction of renal microsomal enzyme systems: ultrastructural effects on pars recta (S3) proximal tubule cells of the rat kidney, J. Pharmacol. Exp. Ther., 203: 712–721 (1977).

    Google Scholar 

  64. R. E. Faith and J. A. Moore, Impairment of thymus-dependent immune functions by exposure of the developing immune system to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), J. Toxicol. Environ. Health, 3: 451–464 (1977).

    Article  Google Scholar 

  65. I. P. Lee and R. L. Dixon, Factors influencing reproduction and genetic toxic effects on male gonads, Environ. Health Perspect., 24: 117–127 (1978).

    Article  Google Scholar 

  66. B. Forsgren, P. Björk, K. Carlström, J.- Å Gustafsson, Å. Pousette, and B. Högberg, Purification and distribution of a major protein in rat prostate that binds estramustine, a nitro gen mustard derivative of estradiol-173, Proc. Natl. Acad. Sci. USA, 76: 3149–3153 (1979).

    Article  ADS  Google Scholar 

  67. B. Forsgren, J.- Å. Gustafsson, Å. Pousette, and B. Högberg, Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17β-estradiol, Cancer Res., 39:5155–5164 (1979).

    Google Scholar 

  68. P. Björk, B. Forsgren, J.- Å. Gustafsson, Å. Pousette, and B. Högberg, Partial characterization and quantitation of a human prostatic estramustine binding protein, Cancer Res., 42: 1935–1942 (1982).

    Google Scholar 

  69. J.- Å. Gustafsson, P. S’derkvist, T. Haaparanta, L. Busk, Å. Pousette, H. Glaumann, R. Toftgård, and B. Högberg, Induction of cytochrome P-450 and metabolic activation of mutagens in the rat ventral prostate, in: The Prostatic Cell: Structure and Function, Part B, Alan R. Liss, Inc., New York, 191–205 (1981).

    Google Scholar 

  70. J. C. Nunnink, A. H. L. Chuang, and E. Bresnick, The ontogeny of nuclear aryl hydrocarbon hydroxylase, Chem.-Biol. Interact., 22: 225–230 (1978).

    Article  Google Scholar 

  71. D. W. Nebert, F. M. Goujon, and J. E. Gielen, Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple automsomal dominant trait in the mouse, Nat. New. Biol., 236: 107–110 (1972).

    Google Scholar 

  72. L. W. Wattenberg, Studies of polycyclic hydrocarbon hydroxylases of the intestine possibly related to cancer: effect of diet on benzpyrene hydroxylase activity, Cancer, 28: 99–102 (1971).

    Article  Google Scholar 

  73. L. W. Wattenberg, W. D. Loub, K. L. Lam, and J. L. Speier, Dietary constituents altering the responses to chemical carcinogens, Fed. Proc., 35: 1327–1331 (1976).

    Google Scholar 

  74. G. Johansson, M. Gillner, B. Högberg, and J.- Å. Gustafsson, The TCDD receptor in rat intestinal mucosa and its possible dietary ligands, Nutrition and Cancer, 1982, 134–144.

    Google Scholar 

  75. J. N. Pitts, D. Grosjean, T. M. Mischke, V. Simmon, and D. Poule, Mutagenic activity of airborne particulate organic pollutants, Toxicol. Letters, 1: 65–70 (1977).

    Article  Google Scholar 

  76. R. Talcott and E. Wei, Airborne mutagens bioassayed in Salmonella typhimurium, J. Natl. Cancer Inst., 58: 449–451 (1977).

    Google Scholar 

  77. G. Löfroth, E. Hefner, I. Alfheim, and M. Møller, Mutagenic activity in photocopies, Science, 209: 1037–1039 (1980).

    Article  ADS  Google Scholar 

  78. H. S. Rosenkranz, E. C. McCoy, D. R. Sanders, M. Butler, D. K. Kiriazides, and R. Mermelstein, Nitropyrenes: Isolation, identification, and reduction of mutagenic impurities in carbon black and toners, Science, 209: 1039–1043 (1980).

    Article  ADS  Google Scholar 

  79. E. Agurell and G. Löfroth, Presence of various types of mutagenic impurities in carbon black detected by the Salmonealla/ microsome assay, in: Short-term Bioassays in the Analysis of Complex Environmental Mixtures III (M. D. Waters, S. S. Sandhu, J. Lewtas, L. Claxton, and S. Nesnow, eds.), Plenum Press, New York (in press).

    Google Scholar 

  80. L. Rudling, B. Ahling, and G. Löfroth, Chemical and biological characterization of emissions from combustion of wood and wood- chips in small furnaces and stoves, in: Residential Solid Fuels, Environmental Impacts and Solutions (J. A. Copper and D. Malek, eds.), Beaverton, OR: Oregon Graduate Center, 34–53 (1981).

    Google Scholar 

  81. J. N. Pitts, Jr., D. M. Lokensgard, W. P. Harger, T. S. Fisher, V. Mejia, J. J. Schuler, G. M. Scorziell, and Y. A. Katzenstein, Mutagens in diesel exhaust: Identification and direct activities of 6-nitrobenzo(a)pyrene, 9-nitroanthracene, 1-nitro- pyrene and 5H-phenanthro[4,5-bcd]pyran-5-one, Mut. Res. (in press).

    Google Scholar 

  82. D. Schuetzle, Sampling of vehicle emissions for chemical analysis and biological testing, Environ. Health Persp. (in press).

    Google Scholar 

  83. C. Y. Wang, M. S. Lee, C. M. King, and P. O. Warner, Evidence for nitroaromatics as direct-acting mutagens of airborne particles, Chemosphere, 9: 83–87 (1980).

    Article  Google Scholar 

  84. G. Löfroth, Comparison of the mutagenic activity in carbon particulate matter and in diesel and gasoline engine exhaust, in: Short-term Bioassays in the Analysis of Complex Environmental Mixtures II (M. D. Waters, S. S. Sandhu, J. Lewtas Huisingh, L. Claxton, and S. Newnow, eds.), Plenum Press, New York, 319–336 (1981).

    Google Scholar 

  85. J. N. Pitts, Jr., W. Harger, D. M. Lokensgard, D. R. Fitz,G. M. Scorziell, and V. Mejia, Diurnal variation in the mutagenicity of airborne particulate organic matter in California’s South Coast air basin, Mut. Res. (in press).

    Google Scholar 

  86. R. Mermelstein, D. K. Kiriazides, M. Butler, E. C. McCoy, and H. S. Rosenkranz, The extraordinary mutagenicity of nitro-pyrenes in bacteria, Mut. Res., 89: 187–196 (1981).

    Article  Google Scholar 

  87. E. C. McCoy, H. S. Rosenkranz, and R. Mermelstein, Evidence for the existence of a family of bacterial nitroreductases capable of activating nitrated polycyclics to mutagens, Environ. Mut., 3: 421–427 (1981).

    Article  Google Scholar 

  88. T. C. Pederson and J. S. Siak, The role of nitroaromatic compounds in the direct-acting mutagenicity of diesel particle extracts, J. Appl. Toxicol., 1: 54–60 (1981).

    Article  Google Scholar 

  89. R. Toftgärd, J. Carlstedt-Duke, R. Kurl, G. Löfroth, and J.- Å. Gustafsson, Compounds in urban air compete with [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin for binding to the receptor protein, Chem.-Biol. Interact, 46: 335–346 (1983).

    Article  Google Scholar 

  90. T. Greibrokk, G. Löfroth, L. Nilsson, R. Toftgärd, J. Carlstedt-Duke, and J.- Å. Gustafsson, Nitroarenes: mutagenicity in the Ames Salmonella/microsome assay and affinity to the TCDD-re- ceptor protein, in: Toxicity of Nitroaromatic Compounds (D. E. Rickert, ed.), Hemisphere Publ. Corp., Washington, D.C. (in press).

    Google Scholar 

  91. A. Poland and E. Glover, 2,3,7,8-tetrachlorodibenzo-p-dioxin: Studies on the mechanism of action, in: The Scientific Basis of Toxicity Assessment (H. Witschi, ed.), Amsterdam/Elsevier, 223–239 (1980).

    Google Scholar 

  92. J. D. McKinney and P. Singh, Structure-activity relationships in halogenated biphenyls: Unifying hypothesis for structural specificity, Chem. Biol. Interact., 33: 271–283 (1981).

    Article  Google Scholar 

  93. R. E. Kouri, L. H. Billups, T. H. Rude, C. E. Whitmire, B. Sass, and C. J. Henry, Correlation of inducibility of aryl hydrocarbon hydroxylase with susceptibility to 3-methylcholanthrene-induced lung cancers, Cancer Letters, 9: 277–284 (1980).

    Article  Google Scholar 

  94. R. A. Prough, Z. Sipal, S. W. Jakobsson, Metabolism of benzo-(a)pyrene in human lung microsomal fractions, Life Sci., 21: 1629–1636 (1977).

    Article  Google Scholar 

  95. A. Poland and E. Glover, 2,3,7,8-tetrachlorodibenzo-p-dioxin: segregation of toxicity with the Ah-locus, Mol. Pharmacol., 17 86–94 (1980).

    Google Scholar 

  96. R. J. Kociba, P. G. Keyes, J. E. Beyer, R. M. Carreon, C. E. Wade, D. A. Dittenberg, R. P. Kalnis, L. E. Frauson, C. N. Park, S. D. Barnard, R. S. Hummel, and C. G. Humiston, Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Toxicol. Appl. Pharmacol., 46: 279–303 (1978).

    Article  Google Scholar 

  97. J. S. Wasson, J. E. Huft, and N. Loprieno, A review on the genetic toxicology of chlorinated dibenzo-p-dioxins, Mut. Res., 47:141–160 (1977–78).

    Google Scholar 

  98. A. Poland and E. Glover, An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat liver protein, ribosomal RNA and DNA, Cancer Res., 39: 3341–3344 (1979).

    Google Scholar 

  99. H. C. Pitot, T. Goldsworthy, H. A. Campbell, and A. Poland, Quantitative evaluation of the promotion by 2,3,7,8-tetra-chlorodibenzo-p-dioxin of hepatocarcinogenesis from diethyl- nitrosamine, Cancer Res., 40: 3616–3620 (1980).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Gustafsson, J.Å. et al. (1984). On the Possible Significance of TCDD Receptor Based Assays in Attempts to Estimate Environmental Health Hazards. In: de Serres, F.J., Pero, R.W. (eds) Individual Susceptibility to Genotoxic Agents in the Human Population. Environmental Science Research, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2765-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2765-3_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9709-3

  • Online ISBN: 978-1-4613-2765-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics